Home Health First Trial of Experimental Bundibugyo Ebola Treatments...
Health

First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100

First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100
Key Points

First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100 Patients with the Bundibugyo strain of Ebola have started receiving experimental treatments in a clinical trial that aims to improve care for the rare viral disease, which has killed more than 500 people in Democratic Republic of Congo. The World Health Organization-sponsored trial will test Mapp Biopharmaceutical Inc.’s monoclonal antibody cocktail MBP134 and Gilead Sciences Inc.’s antiviral...

First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100 Patients with the Bundibugyo strain of Ebola have started receiving experimental treatments in a clinical trial that aims to improve care for the rare viral disease, which has killed more than 500 people in Democratic Republic of Congo. The World Health Organization-sponsored trial will test Mapp Biopharmaceutical Inc.’s monoclonal antibody cocktail MBP134 and Gilead Sciences Inc.’s antiviral remdesivir alongside optimized supportive care in Congo’s Ituri province, where the outbreak is concentrated.
Congo (LOCATION) Bundibugyo (LOCATION) Democratic Republic of Congo (LOCATION) The World Health Organization (ORG) Mapp Biopharmaceutical Inc.’s (ORG) Gilead Sciences Inc.’s (ORG) Ituri (ORG)
Originally published by Bloomberg Technology Read original →